Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Rheumatoid Arthritis
•
General Rheumatology
•
TNF inhibitor
How do you manage transaminitis in a patient receiving TNF alpha inhibitors?
Related Questions
How do you approach treatment of a patient with active RA and a history of Lynch Syndrome?
What is your approach to methotrexate use (or avoidance) in patients with varying MTHFR mutations?
Do you continue TNF inhibitors in patients with a new diagnosis of CLL?
What is your approach to differentiating RA-ILD from medication toxicity (I.e. from methotrexate)?
How do you approach use of DMARDs and/or biologics for inflammatory arthritis in patients with a history of seizure disorder on anti-epileptic medications?
What is your approach to assessing inflammatory arthritis flares in joints that have been replaced (such as knees)?
For patients who do not have access to biologic therapies, what are some csDMARD combination pearls or tips that you have that have particular efficacy in different rheumatologic diseases?
What is your approach to differentiating tender spots (as in fibromyalgia) and enthesitis (as in axSpA)?
In patients with diffuse scleroderma and symptomatic lower extremity venous insufficiency, would you recommend treatment with endovenous laser/ablation?
What is your approach to monitoring patients referred for high titer +RF and +CCP but without active symptoms of inflammatory arthritis?
